Vita Life Sciences Limited (VLS.AX)

AUD 1.78

(0.0%)

Total Liabilities Summary of Vita Life Sciences Limited

Vita Life Sciences Limited's latest annual total liabilities in 2023 was 16.47 Million AUD , up 7.71% from previous year.
Vita Life Sciences Limited's latest quarterly total liabilities in 2024 Q2 was 19.25 Million AUD , down 0.0% from previous quarter.
Vita Life Sciences Limited reported annual total liabilities of 15.29 Million AUD in 2022, up 3.02% from previous year.
Vita Life Sciences Limited reported annual total liabilities of 14.84 Million AUD in 2021, up 1.27% from previous year.
Vita Life Sciences Limited reported quarterly total liabilities of 16.47 Million AUD for 2023 Q4, down 0.0% from previous quarter.
Vita Life Sciences Limited reported quarterly total liabilities of 16.47 Million AUD for 2023 FY, up 7.71% from previous quarter.

Annual Total Liabilities Chart of Vita Life Sciences Limited (2023 - 2007)

Historical Annual Total Liabilities of Vita Life Sciences Limited (2023 - 2007)

Year	Total Liabilities	Total Liabilities Growth
2023	16.47 Million AUD	7.71%
2022	15.29 Million AUD	3.02%
2021	14.84 Million AUD	1.27%
2020	14.66 Million AUD	4.88%
2019	13.97 Million AUD	5.0%
2018	13.31 Million AUD	63.13%
2017	8.16 Million AUD	-11.14%
2016	9.18 Million AUD	-3.45%
2015	9.51 Million AUD	9.26%
2014	8.7 Million AUD	51.67%
2013	5.74 Million AUD	4.92%
2012	5.47 Million AUD	24.54%
2011	4.39 Million AUD	-31.17%
2010	6.38 Million AUD	30.01%
2009	4.9 Million AUD	2.38%
2008	4.79 Million AUD	24.56%
2007	3.84 Million AUD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	19.25 Million AUD	0.0%
2023 Q4	16.47 Million AUD	0.0%
2023 FY	16.47 Million AUD	7.71%
2023 Q2	14.99 Million AUD	0.0%
2022 Q4	15.29 Million AUD	0.0%
2022 FY	15.29 Million AUD	3.02%
2022 Q2	15.8 Million AUD	0.0%
2021 FY	14.84 Million AUD	1.27%
2021 Q2	13.79 Million AUD	0.0%
2021 Q4	14.84 Million AUD	0.0%
2020 FY	14.66 Million AUD	4.88%
2020 Q2	14.4 Million AUD	0.0%
2020 Q4	14.66 Million AUD	0.0%
2019 Q2	13.15 Million AUD	0.0%
2019 FY	13.97 Million AUD	5.0%
2019 Q4	13.97 Million AUD	0.0%
2018 Q2	9.94 Million AUD	0.0%
2018 FY	13.31 Million AUD	63.13%
2018 Q4	13.31 Million AUD	0.0%
2017 Q2	8.36 Million AUD	0.0%
2017 Q4	8.16 Million AUD	0.0%
2017 FY	8.16 Million AUD	-11.14%
2016 Q2	9.61 Million AUD	0.0%
2016 FY	9.18 Million AUD	-3.45%
2016 Q4	9.18 Million AUD	0.0%
2015 Q2	9.35 Million AUD	0.0%
2015 Q4	9.51 Million AUD	0.0%
2015 FY	9.51 Million AUD	9.26%
2014 FY	8.7 Million AUD	51.67%
2014 Q4	8.7 Million AUD	0.0%
2014 Q2	5.2 Million AUD	0.0%
2013 Q2	6.27 Million AUD	0.0%
2013 FY	5.74 Million AUD	4.92%
2013 Q4	5.74 Million AUD	0.0%
2012 FY	5.47 Million AUD	24.54%
2012 Q4	5.47 Million AUD	0.0%
2011 FY	4.39 Million AUD	-31.17%
2011 Q4	4.39 Million AUD	0.0%
2010 Q4	6.38 Million AUD	0.0%
2010 FY	6.38 Million AUD	30.01%
2009 Q4	4.9 Million AUD	0.0%
2009 FY	4.9 Million AUD	2.38%
2008 FY	4.79 Million AUD	24.56%
2008 Q4	4.79 Million AUD	0.0%
2007 FY	3.84 Million AUD	0.0%

Peer Total Liabilities Comparison of Vita Life Sciences Limited

Name	Total Liabilities	Total Liabilities Difference
Althea Group Holdings Limited	23.33 Million AUD	29.4%
Cann Group Limited	78.85 Million AUD	79.105%
ECS Botanics Holdings Ltd	4.66 Million AUD	-252.903%
Ecofibre Limited	30.27 Million AUD	45.586%
Elixinol Wellness Limited	5.24 Million AUD	-213.888%
Hygrovest Limited	2.68 Million AUD	-514.547%
IDT Australia Limited	7.93 Million AUD	-107.768%
Invion Limited	1.01 Million AUD	-1525.149%
Little Green Pharma Ltd	16.39 Million AUD	-0.516%
Live Verdure Ltd	1.95 Million AUD	-743.058%
Medical Developments International Limited	13.42 Million AUD	-22.708%
Vitura Health Limited	32.83 Million AUD	49.828%